Bio-adrenomedullin: A weak biomarker for a STRONG patient.
Publication
, Journal Article
Bayes-Genis, A; Greene, SJ
Published in: Eur J Heart Fail
July 2024
Duke Scholars
Published In
Eur J Heart Fail
DOI
EISSN
1879-0844
Publication Date
July 2024
Volume
26
Issue
7
Start / End Page
1493 / 1494
Location
England
Related Subject Headings
- Prognosis
- Humans
- Heart Failure
- Cardiovascular System & Hematology
- Biomarkers
- Adrenomedullin
- 3201 Cardiovascular medicine and haematology
- 1102 Cardiorespiratory Medicine and Haematology
Citation
APA
Chicago
ICMJE
MLA
NLM
Bayes-Genis, A., & Greene, S. J. (2024). Bio-adrenomedullin: A weak biomarker for a STRONG patient. Eur J Heart Fail, 26(7), 1493–1494. https://doi.org/10.1002/ejhf.3351
Bayes-Genis, Antoni, and Stephen J. Greene. “Bio-adrenomedullin: A weak biomarker for a STRONG patient.” Eur J Heart Fail 26, no. 7 (July 2024): 1493–94. https://doi.org/10.1002/ejhf.3351.
Bayes-Genis A, Greene SJ. Bio-adrenomedullin: A weak biomarker for a STRONG patient. Eur J Heart Fail. 2024 Jul;26(7):1493–4.
Bayes-Genis, Antoni, and Stephen J. Greene. “Bio-adrenomedullin: A weak biomarker for a STRONG patient.” Eur J Heart Fail, vol. 26, no. 7, July 2024, pp. 1493–94. Pubmed, doi:10.1002/ejhf.3351.
Bayes-Genis A, Greene SJ. Bio-adrenomedullin: A weak biomarker for a STRONG patient. Eur J Heart Fail. 2024 Jul;26(7):1493–1494.
Published In
Eur J Heart Fail
DOI
EISSN
1879-0844
Publication Date
July 2024
Volume
26
Issue
7
Start / End Page
1493 / 1494
Location
England
Related Subject Headings
- Prognosis
- Humans
- Heart Failure
- Cardiovascular System & Hematology
- Biomarkers
- Adrenomedullin
- 3201 Cardiovascular medicine and haematology
- 1102 Cardiorespiratory Medicine and Haematology